aap Quarterly Statement 1st quarter 2019

Quarterly Statement | 1st quarter 2019 aap 11 Sales for the last four quarters 2) Closing prices XETRA; data source: Bloomberg 31 Bloomberg adjusted the share price data from 01/01/2019 to 31/03/2019 retrospectively by a subscription right deduction from the recent capital increase with subscription rights Note: The figures contained in this quarterly statement are unaudited. Technical rounding differences could exist, which have no impact on the entire statement. Product image front page: Distal Tibia Plating System 3.5

Quarterly Statement | 1st quarter 2019 Table of Contents Selected Figures Business Review • Foreword by the Management Board •. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 • Significant Events • • Significant Development Activities • • Earnings Position • • Asset Position • • Financial Position • • Risk and Opportunity Report • • Outlook • • Supplementary Report • Selected Financial Data...

Quarterly Statement | 1st quarter 2019 Business Review Foreword by the Management Board Ladies and Gentlemen, Locking Compression Technology by aap Dear Shareholders, Dear Employees and Business Partners, we have made a successful start to the 2019 financial year with significant sales growth and substantial earnings improvement. Both sales and EBITDA were above our guidance. We have therefore set a solid foundation for the planned dynamic sales growth and earnings improvement for the full year. Upper Lower With a view to the sales development, all regions contributed with double-digit growth...

Quarterly Statement | 1st quarter 2019 As part of the further completion of our LOQTEQ® portfolio, in In connection with the package of measures adopted in April the first quarter we have placed particular focus on polyaxial to strengthen our financial base we recently successfully com- fixation technology, plating systems for the foot and ankle pleted a capital increase with subscription rights with gross is- areas, as well as implants in sterile packaging. Furthermore, the suing proceeds of around EUR 3.5 million. With the cash inflow focus remained on adapting processes and documents to new...

Quarterly Statement | 1st quarter 2019 Significant Events Earnings Position During the first quarter of 2019, there were no events that had Sales and margin development as well as total ope- a significant impact on the earnings, asset or financial position rating performance aap had a successful start to financial year 2019 with significant sales growth. The company increased sales in the first Significant Development Activities quarter of 2019 by 26% to EUR 3.5 million compared to the In the LOQTEQ® area, aap concentrated its development acti- same period in the previous year (Q1/2018: EUR 2.8 million)....

Quarterly Statement | 1st quarter 2019 Cost Structure and Result Asset Position The personnel expenses decreased in the reporting period by aap’s balance sheet had not changed significantly at the end EUR 0.1 million to EUR 1.9 million compared to the first quarter of the first quarter of 2019 compared to 12/31/2018. Total as- of 2018 (Q1/2018: EUR 2.0 million). The personnel cost ratio (in sets dropped by 3% from EUR 42.2 million at year-end 2018 relation to total operating performance) decreased accordingly from 74% to 65% with an increase in total operating performance. The increase in non-current...

Quarterly Statement | 1st quarter 2019 Cash and cash equivalents fell in the first quarter of 2019 and Cash flow from investing activities increased to EUR -1.0 mil- amounted to EUR 2.7 million on the balance sheet due date lion in the first quarter of 2019 (Q1/2018: EUR -0.5 million). In (12/31/2018: EUR 4.3 million). Together with the tied-up liqui- the first quarter of 2019, investments in development projects dity holdings under the current and non-current other financial accounted for EUR 0.4 million (Q1/2018: EUR 0.3 million) and assets, the cash holdings as at 03/31/2019 amounted to EUR property,...

Quarterly Statement | 1st quarter 2019 Risk and Opportunity Report time still Member of the Supervisory Board at aap, as successor The risk and opportunity situation of aap Implantate AG has and new Chairman of the Management Board / CEO with effect not materially changed since the year end 2018. There are still as of 1 May 2019. In addition, the Management Board and Su- no risks that would threaten the company’s continued exis- pervisory Board of aap resolved to propose Ms. Dr. Natalie Krebs tence. All existing risks and opportunities as well as the to the competent commercial register for a...

Quarterly Statement | 1st quarter 2019 aap aap Implantate AG Lorenzweg 5 • 12099 Berlin • Germany

Quarterly Statement | 1st quarter 2019 aap LIABILITIES AND SHAREHOLDERS' EQUITY (KEUR) 2019 2018 aap Implantate AG Lorenzweg 5 • 12099 Berlin • Germany

Quarterly Statement | 1st quarter 2019 aap INCOME STATEMENT (KEUR) 2019 2018 aap Implantate AG Lorenzweg 5 • 12099 Berlin • Germany

Quarterly Statement | 1st quarter 2019 aapConsolidated Statement of Cash Flows (unaudited) (KEUR) 2019 2018 aap Implantate AG Lorenzweg 5 • 12099 Berlin • Germany

Quarterly Statement | 1st quarter 2019 aap Consolidated Statement of Changes in Equity (unaudited) aap Implantate AG Lorenzweg 5 • 12099 Berlin • Germany

Quarterly Statement | 1st quarter 2019 Company Calendar 2019 • May 14, 2019 Fruhjahrskonferenz 2018 (Analyst Meeting) Frankfurt am Main • June 21, 2019 Annual General Meeting Berlin • August 14, 2019 Interim report 2nd quarter 2019 • November 14, 2019 Quarterly statement 3rd quarter 2019 • November 25 - 27, 2019 German Equity Forum 2019 (Analyst Meeting) Frankfurt am Main Forward-looking statements This report contains forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of future...